Literature DB >> 3067491

Hemodilution--possibilities and safety aspects.

K Messmer1.   

Abstract

Normovolemic hemodilution is an essential part of the overall strategy to avoid exposure of patients to the hazards of homologous blood transfusions. It includes beneficial effects on the flow properties and flow conditions of blood. A hematocrit of 30% can be regarded as an optimal compromise between the fluidity and the oxygen content of the blood. Compensatory responses such as increased cardiac output and stroke volume occur following hemodilution. In patients with compromised coronary reserve the degree of hemodilution that is tolerated has to be carefully considered. Therefore specific selection criteria for patients to be preoperatively hemodiluted are needed. For reasons of safety, efficiency and practicability colloid solutions rather than crystalloid solutions should be used for intentional hemodilution.

Entities:  

Mesh:

Year:  1988        PMID: 3067491     DOI: 10.1111/j.1399-6576.1988.tb02843.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand Suppl        ISSN: 0515-2720


  4 in total

Review 1.  [Normovolemic hemodilution].

Authors:  D J Cŏté
Journal:  Can J Anaesth       Date:  1991-03       Impact factor: 5.063

2.  Isovolemic hemodilution increases retinal tissue oxygen tension.

Authors:  K A Neely; J T Ernest; T K Goldstick; R A Linsenmeier; J Moss
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-11       Impact factor: 3.117

3.  Evaluation of acute normovolemic hemodilution and autotransfusion in neurosurgical patients undergoing excision of intracranial meningioma.

Authors:  Imtiaz A Naqash; M A Draboo; Abdul Qayoom Lone; Showkat H Nengroo; Altaf Kirmani; Abdul Rashid Bhat
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-01

4.  Utility of Acute Normovolemic Hemodilution in Major Surgeries in Rural Area: A Prospective Comparative Study from North India.

Authors:  Sujeet Rai; Satyajeet Verma; Pramod Kumar Yadav; Jawed Ahmad; Harikesh Kumar Yadav
Journal:  Anesth Essays Res       Date:  2017 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.